Suzhou Sepax Technologies Co., Ltd. Class A
SSSE:68875822.42
CNY
-0.75
(-3.24%)
ISIN
CNE100006ZW3
Return %
Stock
S&P 500
1Y
19.32
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Quarterly Revenue
CNY
•
in mil. unless spec.Quarterly Earnings Per Share
CNY
•
in mil. unless spec.Quarterly Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Xue Ying Huang
- Full Time Employees
- 417
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Suzhou China
- IPO Date
- Jan 10, 2025
- Website
- sepax-tech.com.cn
- Similar Companies
- Business
- Suzhou Sepax Technologies Co., Ltd. is a China-based biotechnology and specialty chemical company that specializes in the research, development, manufacture, and commercialization of liquid chromatography materials, separation media, and analytical consumables. Founded in 2009 and headquartered in Suzhou, Jiangsu Province, China, with international operations and research facilities in Newark, Delaware, United States, the company serves the biopharmaceutical, pharmaceutical, clinical diagnostics, food safety, and environmental testing industries across China, North America, Europe, and the Asia-Pacific region. The company operates through two primary business segments: Chromatography Media for Bioprocessing and Analytical Columns and Consumables. Its comprehensive product portfolio includes industrial bioprocess chromatography media, featuring affinity chromatography resins such as recombinant Protein A media for monoclonal antibody purification, ion exchange resins, hydrophobic interaction chromatography resins, size exclusion chromatography media, reversed-phase polymeric resins, and mixed-mode media for the downstream purification of vaccines, nucleic acid therapeutics, recombinant proteins, antibody-drug conjugates, and peptides; analytical and preparative liquid chromatography columns, encompassing high-performance liquid chromatography and ultra-high-performance liquid chromatography columns for aggregate analysis, charge variant analysis, titer determination, and molecular weight distribution profiling; chromatography hardware, pre-packed columns, and sample preparation consumables, including solid-phase extraction cartridges and bulk sorbents; and downstream technical services, comprising chromatographic process development, column packing services, analytical method validation, and regulatory documentation support for biopharmaceutical manufacturing. In recent operational developments, Suzhou Sepax Technologies successfully completed its initial public offering and listed its Class A shares on the Science and Technology Innovation Board of the Shanghai Stock Exchange under ticker 688758 in early 2024. The company has expanded its commercial-scale chromatography media production facilities in Suzhou to meet growing global biomanufacturing demand, launched next-generation high-capacity Protein A resins and specialized separation media designed for messenger ribonucleic acid and viral vector purification, and entered strategic supply and process development partnerships with multinational biopharmaceutical manufacturers and contract development and manufacturing organizations to accelerate the international adoption of its separation and purification technologies.